Results 91 to 100 of about 111,828 (202)

Plasminogen Activator Inhibitor-1

JACC: Basic to Translational Science, 2022
Dimitri Arangalage, Gregory Franck, Giuseppina Caligiuri   +2 more
openaire   +1 more source

Increased hazard of myocardial infarction with insulin‐provision therapy in actively smoking patients with diabetes mellitus and stable ischemic heart disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial [PDF]

, 2017
Background In the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial, randomization of diabetic patients with stable ischemic heart disease to insulin provision ( IP
Brown, David L, Chung, Matthew J, Khan, Asrar A, Novak, Eric   +3 more
core   +2 more sources

ANGIOTENSIN CONVERTING ENZYME GEN POLIMORPHISM AND ITS RELATION WITH PLASMINOGEN ACTIVATOR INHIBITOR-1 IN CHRONIC DIALYSIS PATIENTS

Turkish Journal of Nephrology, 2019
It is well known that coronary events and changes in the fibrinolytic system are common complications seen in end stage renal disease (ESRD) patients. Previous studies have shown that the activities of the enzymes of fibrinolytic pathway differ between ...
İ. Çetin ÖZENER, Emel KARIŞIK, Azra BİHORAC, Mehmet KOÇ, Turgay İSPİR, Emel AKOĞLU   +5 more
doaj  

The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation

Cells
Chronic inflammatory diseases, such as rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, Crohn’s disease, periodontitis, and carcinoma metastasis frequently result in bone destruction.
Yosuke Kanno
doaj   +1 more source

Angiogenesis outcomes of metformin utilization in diabetes mellitus: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To review relevant literature regarding the role of metformin in angiogenesis among diabetic patients. Method: The systematic review and meta-analysis conducted from May to September 2022, and comprised search on Medline, ScienceDirect ...
Primasitha Maharani Harsoyo, Hanestya Oky Hermawan, Arisvia Sukma Hariftyani, Farah Aisha Shabrina, Anisya Dinda Paramitha, Saskia Ratna Desita, Yudi Her Oktaviono   +6 more
doaj   +1 more source

Different effects of oral and transdermal hormone replacement therapies on Factor IX, APC resistance, t-PA, PAI and C- reactive protein - a cross-sectional population survey [PDF]

, 2001
The effects of hormone replacement therapy (HRT) on thrombosis risk, thrombotic variables, and the inflammatory marker C- reactive protein (CRP) may vary by route of administration (oral versus transdermal).
Lowe, G.D.O., McConnachie, A., O'Reilly, D.S., Rumley, A., Upton, M.N., Watt, G.C.M.   +5 more
core  

SARS-CoV Regulates Immune Function-Related Gene Expressions in Human Monocytic Cells [PDF]

, 2011
Background: Severe Acute Respiratory Syndrome (SARS) is characterized by acute respiratory distress (ARDS) and pulmonary fibrosis, and the monocyte/macrophage is the key player in the pathogenesis of SARS. Methods: In this study, we ...
Betty A. Wu-Hsieh, Chuan-Liang Kao, Sher Singh, Wan-Jiung(Wan-Chung) Hu, Yu-Ting Yen   +4 more
core   +1 more source

Plasminogen Activator Inhibitor 1 [PDF]

, 2020
openaire   +1 more source

Type 1 plasminogen activator inhibitor

Japanese Journal of Thrombosis and Hemostasis, 1990
openaire   +3 more sources

Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]

Front Oncol
Al Shaer NSH, Tleyjeh A, Al-Attas MA, Alibrahim JH, Khan MI, Yaqinuddin A.   +5 more
europepmc   +1 more source